PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
PHXM was delisted on the 8th of March, 2024.
9 hedge funds and large institutions have $374K invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
53% more capital invested
Capital invested by funds: $245K → $374K (+$130K)
13% more funds holding
Funds holding: 8 → 9 (+1)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$189K |
| 2 |
Millennium Management
New York
|
+$23.8K |
| 3 |
VF
Virtu Financial
New York
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
-$189K |
| 2 |
Mariner
Overland Park,
Kansas
|
-$23.6K |
| 3 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$23.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IC
1
Ikarian Capital
Dallas,
Texas
| $252K | +$189K | +24,541 | +8,126% |
|
|
2
Millennium Management
New York
| $30K | +$23.8K | +3,080 | New |
|
|
VPIM
3
Vanguard Personalized Indexing Management
Oakland,
California
| $23.8K | -$23.6K | -3,057 | -56% |
|
|
4
Mariner
Overland Park,
Kansas
| $23K | -$23.6K | -3,057 | -56% |
|
|
VF
5
Virtu Financial
New York
| $20K | +$15.5K | +2,003 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $10.6K | -$20.7K | -2,678 | -71% |
|
7
Group One Trading
Chicago,
Illinois
| $10.4K | – | – | – |
|
|
ADL
8
Asset Dedication LLC
San Francisco,
California
| $4K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $539 | -$3.25K | -421 | -88% |
|
|
JFG
10
Jefferies Financial Group
New York
| – | -$189K | -57,270 | Closed |
|
PHXM Hedge Fund Activity: Q1 2023 in Review
9 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q1 2023, worth a combined $374K — up 53% from $245K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PHXM positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Ikarian Capital, adding an estimated $189K. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $189K sold.
- 9 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q1 2023, up from 8 in Q4 2022.
- Funds reported $374K of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q1 2023, up 53% quarter-over-quarter.
- 2 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q1 2023 and 1 closed out, a net change of +1 holder.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares buyer in Q1 2023 was Ikarian Capital, an estimated $189K added.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q1 2023 was Jefferies Financial Group, an estimated $189K sold.
Based on aggregated 13F filings for Q1 2023.